معرفی
Molly Carlyle is a part-time Lecturer in the Department of Psychology at the University of Oslo, actively contributing to the LABlab (Leknes Affective Brain lab) with research focused on addiction vulnerability in adolescents and young adults. Her position is explicitly designated as hourly-paid (Bilagslønnede), reflecting her non-full-time academic appointment.
Her educational foundation includes a PhD in Psychopharmacology from the University of Exeter (UK), where she investigated social risk factors in opioid use disorders, followed by postdoctoral development of novel addiction treatments at the University of Queensland (Australia). This dual-experience trajectory bridges experimental and translational research perspectives.
Carlyle's expertise centers on psychopharmacology and the neurobiological underpinnings of substance use disorders. She examines acute/chronic drug effects on cognition and behavior, childhood adversity's role in addiction pathways, drug reward mechanisms, and pharmacologically-assisted psychotherapies. Her work prioritizes translating mechanistic findings into early prevention strategies and novel treatments for mental health and addiction disorders.
Recent publications (2023-2024) demonstrate consistent focus on childhood adversity's modulation of opioid/stimulant responses through placebo-controlled trials in healthy volunteers and surgical outpatients. These studies reveal critical insights into endogenous opioid and dopamine systems in stress recovery and reward processing, directly informing clinical approaches for disorders involving disrupted social-reward pathways.
Within the LABlab, Carlyle leads research on opioid stimulation/blockade impacts using acute administration and social support protocols. This work aims to establish foundational knowledge for treating clinical disorders where stress-reward processing is impaired, particularly emphasizing adolescent and young adult populations.
